Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome

Journal of Cardiovascular Electrophysiology

Volumn 12, Issue 6, 2001, Pages 630-636

  Van Den Berg, Maarten P ^a   Wilde, Arthur A M ^b   Willem Viersma, J A N ^a   Brouwer, J A N ^a   Haaksma, Jaap ^a   Van Der Hout, Annemieke H ^c   Stolte Dijkstra, Irene ^c   Bezzina, Connie R ^b   Van Langen, Irene M ^b   Beaufort Krol, Gertie C M ^a   Hein Cornel, J A N ^d   Crijns, Harry J G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d Location Alkmaar   (Netherlands)

Author keywords

Bradycardia; Brugada syndrome; Long QT syndrome type 3; Pacemaker; Sudden death

Indexed keywords

SODIUM CHANNEL;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BICYCLE ERGOMETRY; BRADYCARDIA; BRUGADA SYNDROME; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; HEART RATE; HOLTER MONITORING; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL; THROMBOSIS;

EID: 0034981834     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2001.00630.x     Document Type: Article

References (30)

1. Aritmie cardiache rare in dell'età pediatrica
2. A new familial cardiac syndrome in children
3. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report
4. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanism
5. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management. Parts I and II
6. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
7. A single sodium channel mutation causing both long-QT and Brugada syndromes
8. Late potentials in a bradycardia-dependent long QT syndrome associated with sudden death during sleep
9. + channel
10. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients
11. Decreased magnitude of heart rate spectral components in coronary artery disease: Its relation to angiographic severity
12. Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation
13. The normal range and determinants of the intrinsic heart rate
14. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
15. Cardiac conduction defects associate with mutations in SCN5A
16. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome
17. Distinct QRS morphology in patients with the SCN5A sodium channel gene mutation (LQT3)
18. Alterations in P wave morphology and prolongation of PR interval duration in the long QT syndrome patients with the SCN5A sodium channel gene mutation
19. 1-subunits
20. + channel
21. The role of a new sodium channel mutation (1795insD) in bradycardia
22. Effects of exercise on heart rate, QT, QTc and QT/QTs in the Romano-Ward inherited long QT syndrome
23. + channel blockade and to increases in heart rate. Implications for gene-specific therapy
24. + channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects in the long-QT syndrome
25. Sodium channel block with mexiletine is effective in reducing dispersion and preventing torsades de pointes in LQT2 and LQT3 models of the long QT syndrome
26. Molecular mechanism for an inherited cardiac arrhythmia
27. Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease
28. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome
29. Influence of the genotype on the clinical course of the long-QT syndrome
30. Long-term follow-up of patients with long-QT syndrome treated with β-blockers and continuous pacing